|
|
|
Insider
Information: |
Crowley John F |
Relationship: |
Director |
City: |
Cranbury |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
590,194 |
|
Indirect Shares
|
97,759 |
|
|
Direct
Value |
$6,379,259 |
|
|
Indirect Value
|
$688,536 |
|
|
Total
Shares |
687,953 |
|
|
Total
Value |
$7,067,795 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amicus Therapeutics Inc |
FOLD |
|
2024-03-01 |
573,478 |
2024-03-01 |
64,895 |
Premium* |
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2023-06-14 |
11,716 |
2021-06-23 |
0 |
Premium* |
|
Entrada Therapeutics, Inc. |
TRDA |
Director |
2022-01-12 |
5,000 |
2022-01-12 |
32,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
298 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-07-02 |
4 |
AS |
$10.92 |
$33,237 |
I/I |
(3,000) |
26,900 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-07-01 |
4 |
AS |
$10.62 |
$35,421 |
I/I |
(3,300) |
28,300 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President & CEO |
|
2009-07-16 |
4 |
AS |
$10.29 |
$36,001 |
D/D |
(3,500) |
69,736 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-06-03 |
4 |
AS |
$10.08 |
$38,032 |
I/I |
(3,700) |
32,400 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President & CEO |
|
2008-10-03 |
4 |
AS |
$14.96 |
$55,381 |
I/I |
(3,700) |
11,400 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President & CEO |
|
2008-08-01 |
4 |
AS |
$15.42 |
$58,605 |
I/I |
(3,800) |
23,200 |
0 |
- |
|
NTLA |
Intellia Therapeutics, In... |
Director |
|
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,425 |
11,716 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-03-03 |
4 |
AS |
$10.00 |
$44,970 |
I/I |
(4,497) |
58,836 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President & CEO |
|
2009-07-14 |
4 |
AS |
$10.28 |
$48,819 |
D/D |
(4,748) |
79,736 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-05-02 |
4 |
AS |
$10.26 |
$49,880 |
I/I |
(4,795) |
35,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President & CEO |
|
2007-12-14 |
4 |
OE |
$0.64 |
$3,190 |
D/D |
5,000 |
48,736 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-06-04 |
4 |
AS |
$10.29 |
$52,038 |
I/I |
(5,000) |
30,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman, President & CEO |
|
2010-11-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
66,634 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2016-05-05 |
4 |
A |
$6.59 |
$32,950 |
D/D |
5,000 |
91,692 |
0 |
- |
|
TRDA |
Entrada Therapeutics, Inc... |
Director |
|
2022-01-12 |
4 |
B |
$9.72 |
$48,575 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-06-15 |
4 |
D |
$8.79 |
$43,994 |
D/D |
(5,005) |
326,606 |
0 |
- |
|
NTLA |
Intellia Therapeutics, In... |
Director |
|
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,197 |
7,291 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-05-01 |
4 |
AS |
$10.34 |
$55,550 |
I/I |
(5,205) |
37,395 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2021-09-03 |
4 |
AS |
$12.02 |
$62,944 |
D/D |
(5,238) |
839,845 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2021-09-03 |
4 |
OE |
$3.53 |
$19,563 |
D/D |
5,238 |
845,083 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-03-04 |
4 |
AS |
$10.00 |
$55,030 |
I/I |
(5,503) |
45,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
President and CEO |
|
2008-04-02 |
4 |
AS |
$10.86 |
$63,903 |
I/I |
(5,800) |
40,900 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-29 |
4 |
AS |
$14.75 |
$87,320 |
D/D |
(5,920) |
328,001 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-29 |
4 |
OE |
$14.75 |
$87,320 |
D/D |
5,920 |
333,921 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2023-11-15 |
4 |
S |
$10.84 |
$65,497 |
D/D |
(6,043) |
889,834 |
0 |
- |
|
298 Records found
|
|
Page 2 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|